Interações de Aztreonam
Aztreonam (Azactam, Cayston), antibiótico, tem 46 interações documentadas nas bulas da FDA e nas fichas informativas que indexamos (graves: 0; moderadas: 46; leves: 0; casos em que uma bula relata não haver interação significativa: 0). Cada item abaixo cita a frase em que se baseia. Esta página de medicamento é um ponto de partida, não um veredito para a sua situação.
Interações segundo a bula
Interações moderadas (46)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (bula de Aztreonam, Advertências e precauções)
Verifique Aztreonam com tudo o que você toma. Adicione sua lista completa; todos os pares são verificados de uma vez.
Abrir no verificadorNão é aconselhamento médico. A gravidade reflete a redação da bula, não as suas circunstâncias. Um alerta “grave” pode ser rotina sob supervisão, e um “leve” pode ser importante em doses altas. Pergunte a um farmacêutico.